塔姆-霍斯法尔蛋白
炎症
巨噬细胞
化学
上睑下垂
细胞生物学
肾
信号转导
组分(热力学)
糖尿病肾病
细胞因子
转染
癌症研究
先天免疫系统
免疫学
作者
Qian-Qian Wu,Si-Qi Peng,Y Zhang,Yan Yang,Wen Shi,Xian‐Li Wen,Zhi-Ying Liu,Xu-Jie Zhou,Ming‐Zhu Zheng,Li-Dan Hu,Xiao-Min Li,J Y Cao,Xinlu Wang,Jun-Lan Yang,Jin-Xuan Wei,Jiajia Shen,Xiao-Xu Wang,B Liu,Xiao‐liang Zhang,Bin Wang
标识
DOI:10.1038/s41467-026-72451-3
摘要
Autosomal dominant tubulointerstitial kidney disease -UMOD is characterized by progressive renal interstitial inflammation and fibrosis. However, its underlying mechanisms remain unclear. Here, we identify a large ADTKD pedigree harboring a novel UMOD p.H36Y mutation. Using CRISPR/Cas9 technology, we generated a UmodH36Y/+ mouse model that recapitulates the key phenotypes observed in affected individuals, including renal dysfunction, cyst formation, and interstitial inflammation. Multi-omics analyses in kidneys from male UmodH36Y/+ mice revealed marked macrophage pyroptosis. Mechanistically, the Umod p.H36Y variant activated the amyloid precursor protein (App)-Cd74 axis which mediated the crosstalk between renal mutant tubular cells and macrophages. This axis sustains NF-κB pathway activation in macrophages, initiating pyroptosis and pro-inflammatory cytokine release. The same mechanism is recapitulated in the UMOD p.Trp31Cys cell model. Notably, Pharmacologic inhibition using ARN2966, a small-molecule App inhibitor, attenuated renal injury in male UmodH36Y/+ mice. Collectively, these findings uncover a targetable pathway in ADTKD-UMOD. This study shows that the UMOD p.H36Y mutation promotes kidney inflammation by enabling mutant tubular cells to trigger macrophage pyroptosis through the App–Cd74 pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI